2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$8.81+$0.44 (+5.26%)
Price as of Sep 14, 2026 7:42 PM EDT- $486.6MMarket Cap
- 31.60%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$8.81+$0.44 (+5.26%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.37 | ||
Change | +$0.07 (+0.84%) | ||
Open | $8.32 | ||
High | $8.67 | ||
Low | $8.26 | ||
Previous Close | $8.30 | ||
Volume | 2,074,936 | ||
30-Day Average Volume | 10,853,940 | ||
1-Week Change | -10.96% | ||
1-Month Change | 112.98% | ||
1-Year Change | 31.60% | ||
3-Year Change | 28.97% | ||
5-Year Change | 70.82% | ||
Fundamentals | |||
Shares Outstanding | 58.1M | ||
Total Assets | $368.7M | ||
Market Cap | $486.6M | ||
Enterprise Value | $465.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$40.7M | ||
Free Cash Flow | -$35.5M | ||
EBIT | -$40.7M | ||
EBITDA | -$40.2M | ||
Net Working Capital | $209.2M | ||
EPS | -$0.70 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | 1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue